TR200103613T2 - Burun içinden tatbik edilen morfini içeren farmasötik formülasyonlar ve yöntemler. - Google Patents
Burun içinden tatbik edilen morfini içeren farmasötik formülasyonlar ve yöntemler.Info
- Publication number
- TR200103613T2 TR200103613T2 TR2001/03613T TR200103613T TR200103613T2 TR 200103613 T2 TR200103613 T2 TR 200103613T2 TR 2001/03613 T TR2001/03613 T TR 2001/03613T TR 200103613 T TR200103613 T TR 200103613T TR 200103613 T2 TR200103613 T2 TR 200103613T2
- Authority
- TR
- Turkey
- Prior art keywords
- pharmaceutical formulations
- administered intranasally
- morphine
- methods containing
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Otolaryngology (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Bu bulus, 3.0' dan 7.0' a kadar bir pH' da morfin ya da farmasötik açidan kabul edilebilir tuzunu içeren, bunun içinden tatbikat için bir farmasötik formülasyona iliskindir. Bu formülasyonlar, morfin ya da farmasötik açidan kabul edilebilir tuzlarinin emilmesinde artis temin etmektedir. Bir düzenlemede, bu bulus, bir memelide bir analjesik ya da anastetik karsiligin orataya çikartilmasi için bir yöntem temin etmektedir, bu yöntem, 3.0' dan 7.0^ a kadar bir pH' da morfin ya da farmasötik açidan kabul edilebilir tuzunun terapötik açidan etkili bir miktarinin burundan tatbik edilmesini kapsamaktadir.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33453799A | 1999-06-16 | 1999-06-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR200103613T2 true TR200103613T2 (tr) | 2004-08-23 |
Family
ID=23307687
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2001/03613T TR200103613T2 (tr) | 1999-06-16 | 2000-05-23 | Burun içinden tatbik edilen morfini içeren farmasötik formülasyonlar ve yöntemler. |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US6677346B1 (tr) |
| EP (2) | EP1183027A4 (tr) |
| JP (1) | JP2003501467A (tr) |
| KR (1) | KR20020016831A (tr) |
| AU (1) | AU774175B2 (tr) |
| BG (1) | BG106221A (tr) |
| BR (1) | BR0012082A (tr) |
| CA (1) | CA2374877C (tr) |
| CZ (1) | CZ20014399A3 (tr) |
| DE (1) | DE10084709T1 (tr) |
| DK (1) | DK200101859A (tr) |
| EE (1) | EE200100677A (tr) |
| ES (1) | ES2197792B1 (tr) |
| FI (1) | FI20012462L (tr) |
| GB (1) | GB2367005A (tr) |
| HR (1) | HRP20010926A2 (tr) |
| HU (1) | HUP0201856A3 (tr) |
| IS (1) | IS6202A (tr) |
| LT (1) | LT4976B (tr) |
| LU (1) | LU90859B1 (tr) |
| LV (1) | LV12859B (tr) |
| MX (1) | MXPA01012879A (tr) |
| NO (1) | NO20015931L (tr) |
| NZ (1) | NZ515783A (tr) |
| PL (1) | PL352556A1 (tr) |
| SE (1) | SE0104203D0 (tr) |
| SI (1) | SI20850A (tr) |
| SK (1) | SK18172001A3 (tr) |
| TR (1) | TR200103613T2 (tr) |
| WO (1) | WO2000076506A1 (tr) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9924797D0 (en) | 1999-10-20 | 1999-12-22 | West Pharm Serv Drug Res Ltd | Compound |
| US20060083691A1 (en) * | 2000-05-10 | 2006-04-20 | Wermeling Daniel P | Intranasal opioid compositions, delivery devices and methods of using same |
| US20040115133A1 (en) * | 2000-05-10 | 2004-06-17 | Wermeling Daniel P. | Intranasal opioid compositions |
| US6572849B2 (en) * | 2000-09-20 | 2003-06-03 | Lee Shahinian, Jr. | Self-preserved antibacterial nasal, inhalable, and topical ophthalmic preparations and medications |
| EP1418862A4 (en) * | 2001-06-29 | 2010-06-09 | Leon J Lewandowski | INDIVIDUALIZED SEARCH THERAPY |
| GB0210264D0 (en) * | 2002-05-03 | 2002-06-12 | Arakis Ltd | The treatment of pain and migraine headache |
| US20040102476A1 (en) * | 2002-11-25 | 2004-05-27 | Chan Tai Wah | High concentration formulations of opioids and opioid derivatives |
| US20050175679A1 (en) * | 2004-02-10 | 2005-08-11 | Michael Moshman | Controlled release formulations |
| US20140162965A1 (en) | 2004-08-25 | 2014-06-12 | Aegis Therapeutics, Inc. | Compositions for oral drug administration |
| US9895444B2 (en) | 2004-08-25 | 2018-02-20 | Aegis Therapeutics, Llc | Compositions for drug administration |
| PT2486942T (pt) | 2004-11-24 | 2019-01-18 | Meda Pharmaceuticals Inc | Composições que compreendem azelastina e seus métodos de utilização |
| US9415034B2 (en) * | 2005-01-05 | 2016-08-16 | National Defense Medical Center | Inhibitors and enhancers of uridine diphosphate-glucuronosyltransferase 2B (UGT2B) |
| ES2277743B2 (es) * | 2005-06-02 | 2008-12-16 | Universidade De Santiago De Compostela | Nanoparticulas que comprenden quitosano y ciclodextrina. |
| ATE458491T1 (de) | 2005-08-26 | 2010-03-15 | Univ Leland Stanford Junior | Verfahren zur behandlung von kopfschmerzen durch verabreichung von oxytocin |
| US20070212307A1 (en) * | 2006-02-10 | 2007-09-13 | Daniel Wermeling | Pharmaceutical Compositions Comprising an Opioid Receptor Antagonist and Methods of Using Same |
| US8226949B2 (en) | 2006-06-23 | 2012-07-24 | Aegis Therapeutics Llc | Stabilizing alkylglycoside compositions and methods thereof |
| WO2008077712A1 (en) * | 2006-12-22 | 2008-07-03 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Gel useful for the delivery of ophthalmic drugs |
| GB2477545B (en) * | 2010-02-05 | 2011-12-21 | Special Products Ltd | A liquid morphine composition for buccal administration |
| LT2706982T (lt) | 2011-05-13 | 2018-05-25 | Euro-Celtique S.A. | Intranazalinės farmacinės vaisto formos, apimančios naloksoną |
| WO2014016653A1 (en) | 2012-07-26 | 2014-01-30 | Wockhardt Limited | Pharmaceutical composition comprising diamorphine for intranasal administration |
| EP3082817A4 (en) * | 2013-12-18 | 2017-06-21 | Aegis Therapeutics, LLC | Compositions for drug administration |
| US11135155B2 (en) | 2014-07-08 | 2021-10-05 | Hikma Pharmaceuticals Usa Inc. | Liquid naloxone spray |
| PL3242676T3 (pl) | 2015-01-07 | 2024-07-15 | Tonix Pharma Limited | Preparaty oksytocyny zawierające magnez i sposoby ich stosowania |
| HUE070412T2 (hu) | 2016-04-12 | 2025-06-28 | Tonix Pharma Ltd | Magnézium tartalmú oxitocin készítmények és alkamazási eljárásaik |
| CA3041309A1 (en) * | 2016-10-21 | 2018-04-26 | Somniferum Labs LLC | Compositions, methods and kits for the safe inhaled delivery of targeted opioids for the treatment of pain and addiction |
| EP3697381B1 (en) * | 2017-10-20 | 2023-06-07 | Chiesi Farmaceutici S.p.A. | Pharmaceutical formulations comprising opioid receptor agonist as active ingredients, methods of manufacture and therapeutic uses thereof |
| WO2019157099A1 (en) | 2018-02-06 | 2019-08-15 | Aegis Therapeutics, Llc | Intranasal epinephrine formulations and methods for the treatment of disease |
| CN115804754A (zh) * | 2022-12-16 | 2023-03-17 | 广州新济药业科技有限公司 | 吗啡鼻喷剂及其制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4464378A (en) * | 1981-04-28 | 1984-08-07 | University Of Kentucky Research Foundation | Method of administering narcotic antagonists and analgesics and novel dosage forms containing same |
| US4464376A (en) | 1982-07-22 | 1984-08-07 | Richardson-Vicks, Inc. | Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same |
| GB8514665D0 (en) * | 1985-06-11 | 1985-07-10 | Eroceltique Sa | Oral pharmaceutical composition |
| US5202128A (en) | 1989-01-06 | 1993-04-13 | F. H. Faulding & Co. Limited | Sustained release pharmaceutical composition |
| GB9202464D0 (en) * | 1992-02-05 | 1992-03-18 | Danbiosyst Uk | Composition for nasal administration |
| DK0689438T3 (da) * | 1993-03-26 | 2003-09-29 | Franciscus Wilhelmus He Merkus | Farmaceutiske præparater til intranasal administration af apomorfin |
| GB9426102D0 (en) | 1994-12-23 | 1995-02-22 | Merck Sharp & Dohme | Pharmacuetical compositions |
| EP1006969A1 (en) * | 1996-09-27 | 2000-06-14 | Nastech Pharmaceutical Co. | Intranasal formulations for promoting sleep and method of using the same |
-
2000
- 2000-05-23 KR KR1020017016009A patent/KR20020016831A/ko not_active Ceased
- 2000-05-23 SI SI200020030A patent/SI20850A/sl not_active IP Right Cessation
- 2000-05-23 EP EP00936212A patent/EP1183027A4/en not_active Withdrawn
- 2000-05-23 GB GB0128383A patent/GB2367005A/en not_active Withdrawn
- 2000-05-23 BR BR0012082-0A patent/BR0012082A/pt not_active IP Right Cessation
- 2000-05-23 DE DE10084709T patent/DE10084709T1/de not_active Ceased
- 2000-05-23 AU AU51561/00A patent/AU774175B2/en not_active Ceased
- 2000-05-23 JP JP2001502839A patent/JP2003501467A/ja active Pending
- 2000-05-23 FI FI20012462A patent/FI20012462L/fi not_active IP Right Cessation
- 2000-05-23 EE EEP200100677A patent/EE200100677A/xx unknown
- 2000-05-23 PL PL00352556A patent/PL352556A1/xx not_active Application Discontinuation
- 2000-05-23 CZ CZ20014399A patent/CZ20014399A3/cs unknown
- 2000-05-23 HR HR20010926A patent/HRP20010926A2/hr not_active Application Discontinuation
- 2000-05-23 ES ES200150086A patent/ES2197792B1/es not_active Expired - Lifetime
- 2000-05-23 CA CA002374877A patent/CA2374877C/en not_active Expired - Fee Related
- 2000-05-23 TR TR2001/03613T patent/TR200103613T2/tr unknown
- 2000-05-23 HU HU0201856A patent/HUP0201856A3/hu unknown
- 2000-05-23 SK SK1817-2001A patent/SK18172001A3/sk unknown
- 2000-05-23 NZ NZ515783A patent/NZ515783A/en unknown
- 2000-05-23 MX MXPA01012879A patent/MXPA01012879A/es unknown
- 2000-05-23 WO PCT/US2000/014157 patent/WO2000076506A1/en not_active Application Discontinuation
- 2000-05-23 EP EP04001252A patent/EP1419774A1/en not_active Withdrawn
- 2000-06-15 US US09/594,916 patent/US6677346B1/en not_active Expired - Fee Related
-
2001
- 2001-12-04 NO NO20015931A patent/NO20015931L/no not_active Application Discontinuation
- 2001-12-12 DK DK200101859A patent/DK200101859A/da not_active Application Discontinuation
- 2001-12-13 LT LT2001119A patent/LT4976B/lt not_active IP Right Cessation
- 2001-12-13 LU LU90859A patent/LU90859B1/en active
- 2001-12-14 IS IS6202A patent/IS6202A/is unknown
- 2001-12-14 BG BG106221A patent/BG106221A/xx unknown
- 2001-12-14 SE SE0104203A patent/SE0104203D0/xx not_active Application Discontinuation
-
2002
- 2002-01-18 LV LVP-01-169A patent/LV12859B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR200103613T2 (tr) | Burun içinden tatbik edilen morfini içeren farmasötik formülasyonlar ve yöntemler. | |
| WO2000021515A3 (en) | Intranasal codeine for the rapid suppression of cough and rapid relief of pain | |
| DK0938316T3 (da) | Opioidantagonistholdig galenisk formulering | |
| WO2002042462A3 (en) | Therapeutic agents and methods of use thereof for treating an amyloidogenic disease | |
| NZ508526A (en) | Opioid formulations for treating pain | |
| DK0754034T3 (da) | Brusende farmaceutiske formuleringer indeholdende biologisk nedbrydelige mikrokapsler med kontrolleret afgivelse | |
| NO925038L (no) | Anordning for nedsettelse av medikamentets hudirriterendevirkninger | |
| NO952906D0 (no) | Farmasöytisk formulering for behandling av nikotinavhengighet | |
| TR199900336T2 (tr) | EAA antagonistleri olarak tetrahidrokinolin türevleri. | |
| DE69824313D1 (de) | Sibutramin und orlistat enthaltende pharmazeutische zusammensetzungen | |
| SE9601528D0 (sv) | Transdermally administered dextromethorphan as antitissue agent | |
| EP0799618A3 (en) | Use of alpha1-adrenoreceptor antagonists in the manufacture of a medicament for the prevention and teatment of cancer | |
| BR0011880A (pt) | Método para o tratamento de condições co-mórbidas associadas com obesidade, composto, produto, uso de um composto, e, composição farmacêutica | |
| AU3278800A (en) | Pharmaceutical composition containing desoxypeganine for the treatment of drug dependence | |
| ATE302010T1 (de) | Pharmazeutische zusammensetzung, enthaltend desoxypeganin zur behandlung des alkoholismus | |
| WO2001000187A3 (en) | Pharmaceutical composition containing sibutramine and a lipase inhibitor | |
| TR200200111T2 (tr) | Neoplazmalar için terapötik ve profilaktik maddeler | |
| BR9607488A (pt) | Um sistema terapêutico transdérmico para a administração de (s)-3-metil-5-(1-metil-2-pirrolidenil)-isoxazol ou um dos seus sais farmaceuticamente aceítaveis | |
| MX9601033A (es) | Nanosuspensiones para administracion intravenosa. |